ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CD55 Variant Associated with Pegylated-interferon α Therapy Response in HBeAg-positive Chronic Hepatitis B Patients

Chen, Jiaxuan; Lou, Shuang; Chen, Haitao; Zhou, Bin; Sun, Jian; Hou, Jinlin; Jiang, De-Ke*南方医科大学; 中山大学
Journal of Clinical and Translational Hepatology2022-6-1DOI: 10.14218/JCTH.2022.00057
3被引5阅读
引用收藏
分享

摘要

Background and Aims: Only a small percentage of chronic hepatitis B (CHB) patients effectively respond to treatment with pegylated-interferon alpha (PegIFN alpha) or nucleos(t)ide analogues (NUCs). We aimed to detect the correlations of complement regulators-associated single-nucleotide polymorphisms (SNPs) with treatment response of hepatitis B e antigen (HBeAg)-positive CHB patients. Methods: A total of 1,763 HBeAg-positive CHB patients were enrolled, 894 received PegIFN alpha for at least 48 weeks and were followed up for 24 weeks, and 869 received NUCs for 104 weeks. For each patient, nine SNPs in genes encoding for complement regulators were determined and genotyped. To assess the cumulative effect of numerous SNPs, a polygenic score (PGS) was utilized. The correlations of SNPs and PGS with the levels of combined response (CR) and hepatitis B s antigen (HBsAg) loss were also investigated. Results: In PegIFN alpha-treated patients, an intronic SNP of CD55, rs28371597, was strongly related to CR, and the CR rate in rs28371597_GG genotype carriers was only approximately half that of rs28371597_GT/ TT genotype carriers (20.29% vs. 37.10%, p=2.00 x 10-3). A PGS incorporating CD55_rs28371597 and two additional SNPs, CFB_rs12614 and STAT4_rs7574865, which had been considered as predictors for PegIFN alpha treatment response before, was strongly correlated with the levels of CR (ptrend=7.94x10-6) and HBsAg loss (p-trend=9.40x10-3) in PegIFN alpha-treated patients. In NUCs-treated individuals, how ever, none of the nine SNPs were shown to be significantly linked to CHB treatment response. Conclusions: CD55_ rs28371597 is a promising biomarker for predicting CHB pa-tients' responsiveness to PegIFN alpha therapy. The updated PGS may be used for optimizing CHB treatment

学科与关键词

关键词
Complement regulatorChronic hepatitis B patientsPolygenic scoreSingle-nucleotide polymorphismTreatment response
相关
加载中…
  • A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
    Li, Jing; Chen, Haitao; Chen, Jiaxuan; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Pharmacogenomics and Personalized Medicine, 2021, 14: 1505-1515.被引 5
  • An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients
    Hou, Jia; Dong, Chao; Chen, Jiaxuan; Chen, Haitao; Na, Rong; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Antiviral Research, 2023, 220: 105741.
  • CXCL13 variant predicts pegylated-interferon a treatment response in HBeAg-positive chronic hepatitis B patients
    Luo, Mengqi; Zhang, Lingyan; Yang, Chou; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Journal of Medical Virology, 2023, 95(7): e28963.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Clinical and Translational Hepatology
发表日期
2022-06-01
卷期
第 11 卷, 第 2 期
页码
295-303
DOI
10.14218/JCTH.2022.00057
期刊等级
2区
成果收录
SCIE
资助标注
National Science and Technology Major Project [2017ZX10202202, 2018ZX10301202]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; National Natural Science Foundation of China [81472618, 81670535, 81802833]; Natural Science Foundation of Guangdong Province [2019A1515011423]; Key-Area Research and Development Program of Guangdong Province [2019B020227004]; Innovative Research Team Project of Guangxi Province [2017GXNSFGA198002]; Dean Fund of Nanfang Hospital, Southern Medical University [2018Z005]; Outstanding Youth Development Scheme of Nanfang Hospital, Southern Medical University [2017J001]; Grant for Recruited Talents to Start Scientific Research from Nanfang Hospital

作者

  • C

    Chen, Jiaxuan (第一作者)

    southern med univ · youjiang med univ nationalities

  • L

    Lou, Shuang

    southern med univ

查看全部 7 位作者收起作者
  • C

    Chen, Haitao

    sun yat sen univ · southern med univ

  • Z

    Zhou, Bin

    southern med univ

  • S

    Sun, Jian

    southern med univ

  • H

    Hou, Jinlin

    southern med univ

  • J

    Jiang, De-Ke (通讯)

    southern med univ · youjiang med univ nationalities

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417